The idea of pharmaceutical clusters is being actively pursued in Russia. Several projects have already been implemented, while others are in the pipeline. There are optimistic reports about regions setting up manufacturing, improving the level of education, and creating jobs, and about pharmaceutical companies receiving infrastructure and tax incentives. Is there reason to expect innovation with pharmaceutical clusters as well? That issue, along with others, was taken up at the International Forum "Innovative Drug Research and Development in Russia" organized by the Adam Smith Institute on November 17-18, 2010, in Moscow.